Edwards' TAVR Platforms Challenged In Boston Scientific Patent Suits
This article was originally published in The Gray Sheet
Executive Summary
More patent litigation is emerging in the transcatheter aortic valve replacement space with two recent lawsuits alleging that Edwards Lifesciences' Sapien 3 TAVR device and delivery systems violated a total of nine patents held by Boston Scientific.